Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows From Operating Activities:
Consolidated Net Income	$ 15,025	$ 8,731
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
Provision for Credit Losses	3,222	1,617
Depreciation and Amortization	1,187	1,110
Net Accretion of Purchase Accounting Adjustments	(2,540)	(552)
Stock Based Compensation Cost	1,197	757
Net Amortization of Securities	1,160	1,703
Loss on Sales of Securities	1	31
Gain on Sale of Loans	(161)	(65)
Income on Other Equity Securities	(420)	(12)
Gain on Sale of Other Real Estate Owned, Net of Writedowns	(209)	(8)
Increase in Cash Value of Life Insurance	(524)	(370)
Deferred Income Tax Expense (Benefit)	1,073	(345)
Changes in Assets and Liabilities:
Decrease in Accrued Interest Receivable	220	2,054
Decrease in Other Assets	2,386	5,587
Increase (Decrease) in Accrued Interest Payable	1,421	(678)
Decrease in Other Liabilities	(100)	(98)
Net Cash Provided by Operating Activities	22,938	19,462
Cash Flows From Investing Activities:
Purchases of Securities Available for Sale	(30,236)	(46,314)
Proceeds from Maturities / Sales of Securities Available for Sale	6,625	26,351
Proceeds from Paydowns of Securities Available for Sale	17,258	29,348
Net Cash Received in Acquisition	0	163,460
Purchases of Other Equity Securities	(11,351)	(386)
Redemption of Other Equity Securities	12,365	35
Purchase of Life Insurance	(2,273)	0
Net Increase in Loans	(192,107)	(236,533)
Net Purchases of Premises and Equipment	(2,075)	(3,899)
Loss on Disposal of Premises and Equipment	0	717
Proceeds from Sales of Other Real Estate	1,026	196
Net (Increase) Decrease in Federal Funds Sold	(88,644)	159,222
Net Cash Used in (Provided by) Investing Activities	(289,412)	92,197
Cash Flows From Financing Activities:
Net Increase (Decrease) in Deposits	(14,167)	103,241
Net Increase (Decrease) in Securities Sold Under Agreements to Repurchase	(3,539)	4,224
Net Increase in Federal Funds Purchased	565	0
Net Repayments on Federal Home Loan Bank Borrowings	(14,966)	(2,940)
Net Proceeds on Bank Term Funding Program	310,000	0
Proceeds from Issuance of Common Stock	0	(48)
Payment of Dividends on Preferred Stock	(1,350)	0
Payment of Dividends on Common Stock	(3,042)	(2,437)
Net Cash Provided by Financing Activities	273,501	102,040
Net Increase in Cash and Cash Equivalents	7,027	213,699
Cash and Cash Equivalents at Beginning of Period	152,740	68,375
Cash and Cash Equivalents at End of Period	159,767	282,074
Supplemental Disclosures for Cash Flow Information:
Interest on Deposits	18,015	2,771
Interest on Borrowings	7,307	1,335
Income Tax Payments	0	12
Supplemental Schedule for Noncash Investing and Financing Activities:
Change in the Unrealized Gain (Loss) on Securities Available for Sale	8,002	(48,954)
Change in the Unrealized Loss on Equity Securities	(134)	(25)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale	(1,662)	10,402
Transfer of Loans to Other Real Estate	810	130
Acquisitions:
Fair Value of Tangible Assets Acquired	0	530,353
Other Intangible Assets Acquired	0	3,875
Liabilities Assumed	0	509,202
Net Identifiable Assets Acquired Over Liabilities Assumed	$ 0	$ 25,026